Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Submission Forms
Promote Your Event
Place an Ad
Weather
News
Local News
Sports
Obituaries
Local Events
Photo Galleries
Video Gallery
e-Edition
Classifieds
Place an ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nkarta Inc
(NQ:
NKTX
)
17.73
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
211
Open
17.73
Bid (Size)
16.75 (1)
Ask (Size)
18.80 (1)
Prev. Close
17.73
Today's Range
17.73 - 17.73
52wk Range
7.550 - 37.68
Shares Outstanding
48,656,798
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Cowen Slashes Price Target On This Stock By Over 78%; Also Check Out Some Other Big PT Changes
August 12, 2022
Cowen & Co. cut the price target for The RealReal, Inc. (NASDAQ: REAL) from $14 to $3. RealReal shares fell 0.7% to $3.1388 in pre-market trading.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2022
July 28, 2022
Via
Benzinga
Performance
YTD
+18.28%
+18.28%
1 Month
+30.46%
+30.46%
3 Month
+28.39%
+28.39%
6 Month
+69.02%
+69.02%
1 Year
-50.42%
-50.42%
More News
Read More
SVB Leerink Picks This Well-Positioned NK Cell-Focused Stock, Sees 117% Upside
July 18, 2022
Via
Benzinga
Expert Ratings for Nkarta
April 26, 2022
Via
Benzinga
Investors Cheer Nkarta's First NK Cell Data With Multiple Complete Responses
April 25, 2022
Via
Benzinga
Will Another Enlivex Innovation Break The Glass Ceiling For Solid Tumor Treatments?
June 14, 2022
Via
Benzinga
Positive Clinical Results Put Nkarta Stock on the Fast Track
May 09, 2022
Via
InvestorPlace
Executives Buy More Than $32M Of 3 Stocks
May 02, 2022
Via
Benzinga
How Is The Market Feeling About Nkarta Inc. - Common Stock?
April 27, 2022
Via
Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
April 26, 2022
Via
Benzinga
71 Biggest Movers From Yesterday
April 27, 2022
Via
Benzinga
Futures Slide Ahead Of Tech Earnings Deluge
April 26, 2022
Via
Talk Markets
The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag For Vascular Biogenics Ovarian Cancer Gene Therapy
April 26, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 26, 2022
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
April 26, 2022
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Eliem Therapeutics Shares Slide
April 25, 2022
Via
Benzinga
60 Biggest Movers From Yesterday
April 26, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 25, 2022
Via
Benzinga
Mid-Day Market Update: Crude Oil Tumbles Over 6%; Nkarta Shares Spike Higher
April 25, 2022
Via
Benzinga
34 Stocks Moving In Monday's Mid-Day Session
April 25, 2022
Via
Benzinga
Why Is Nkarta (NKTX) Stock Soaring 90% Today?
April 25, 2022
Via
InvestorPlace
Mid-Morning Market Update: Markets Open Lower; Dow Tumbles Over 300 Points
April 25, 2022
Via
Benzinga
Benzinga's Daily Brief On Trending Tickers For April 25, 2022: Twitter, Coca-Cola, Nkarta, And More
April 25, 2022
Via
Benzinga
How Nkarta Stock Scored A 90% Surge On Its 'Natural Killers' In Cancer
April 25, 2022
Via
Investor's Business Daily
Why Nkarta Stock Is Soaring Today
April 25, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
